−2.35 TWD
−127.55 M TWD
18.00 K TWD
About MEGAPRO BIOMEDICAL CO LTD
Sector
CEO
Hsien Chih Wang
Headquarters
Hsinchu
Website
Founded
2014
ISIN
TW0006827009
FIGI
BBG012WH5CQ1
MegaPro Biomedical Co., Ltd. engages in the development of drug ingredients related to nanoparticles and nanocell technology platforms. Its products include iron agent for iron deficiency in chronic kidney diseases, contrast agent for liver and lymph nodes magnetic resonance imaging, and anti-cancer drugs. The company was founded on November 7, 2014 and is headquartered in Hsinchu, Taiwan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 6827 is 14.55 TWD — it has increased by 3.56% in the past 24 hours. Watch MEGAPRO BIOMEDICAL CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange MEGAPRO BIOMEDICAL CO LTD stocks are traded under the ticker 6827.
6827 stock has risen by 3.93% compared to the previous week, the month change is a −4.59% fall, over the last year MEGAPRO BIOMEDICAL CO LTD has showed a −39.12% decrease.
6827 reached its all-time high on Oct 19, 2021 with the price of 50.75 TWD, and its all-time low was 13.00 TWD and was reached on Dec 19, 2024. View more price dynamics on 6827 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
6827 stock is 3.44% volatile and has beta coefficient of 0.21. Track MEGAPRO BIOMEDICAL CO LTD stock price on the chart and check out the list of the most volatile stocks — is MEGAPRO BIOMEDICAL CO LTD there?
Yes, you can track MEGAPRO BIOMEDICAL CO LTD financials in yearly and quarterly reports right on TradingView.
6827 net income for the last half-year is −77.23 M TWD, while the previous report showed −65.07 M TWD of net income which accounts for −18.69% change. Track more MEGAPRO BIOMEDICAL CO LTD financial stats to get the full picture.
No, 6827 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 31, 2024, the company has 27.00 employees. See our rating of the largest employees — is MEGAPRO BIOMEDICAL CO LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEGAPRO BIOMEDICAL CO LTD EBITDA is −146.99 M TWD, and current EBITDA margin is −688.16 K%. See more stats in MEGAPRO BIOMEDICAL CO LTD financial statements.
Like other stocks, 6827 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEGAPRO BIOMEDICAL CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEGAPRO BIOMEDICAL CO LTD technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEGAPRO BIOMEDICAL CO LTD stock shows the sell signal. See more of MEGAPRO BIOMEDICAL CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.